Somnogen Canada Inc
 | This article includes a list of general references, but it lacks sufficient corresponding inline citations. (April 2023) |
Somnogen is a Canadian multinational pharmaceutical corporation with its global headquarters located in Toronto, Canada. Somnogen produces and develop a wide range of prescription and over-the-counter medications in the field of sleep medicine. Somnogen has a portfolio of products for major areas within the field of sleep/wake therapeutic segment including insomnia and excessive daytime sleepiness.
Somogen was founded by Seithikurippu Ratnas Pandi-Perumal, who was an Indian-born Canadian citizen. Somnogen initially launched its operation in India with a set of prescription and over-the-counter portfolio sleep medications. Currently the company doesn't have a factory of its own, but contract manufactures its products with othercompanies.
Product portfolio[edit]
Achoosom tablets (Diphenhydramine HCl 10 mg)
Benzax 0.25/0.5 mg tablets (Alprazolam 0.25 mg and 0.5 mg)
Benzax-F tablets (Alprazolam 0.25 mg + Fluoxetine 20 mg)
Depresom-ID tablets (Imipramine HCl 25 mg + Diazepam 5 mg)
Doxesom tablets (Doxepin HCl 3 mg)
Hydrozet-10 tablets (Cetirizine HCl 10 mg)
Loresta tablets (Lorazepam 1 mg and 2 mg)
Somnotril 0.5 tablets (Clonazepam 0.5 mg)
Somnolex tablets (Clonazepam 0.5 mg + Ecitalopram 10 mg)
Tophan capsules (Tryptophan 50 mg)
Xanfeine tablets (Caffeine 100 mg)
Zoltar 5/10 tablets (Zolpidem tartrate 5 mg and 10 mg)